Vertex Pharmaceuticals to Buy Alpine Immune Sciences for $4.9B

Vertex Pharmaceuticals (VRTX.O), opens new tab will buy Alpine Immune Sciences (ALPN.O), opens new tab for about $4.9 billion in cash, gaining access to the biotech firm’s protein-based immunotherapies to treat autoimmune and inflammatory diseases, the companies said on Wednesday. The deal values each share of Alpine at $65, which represents a premium of about 67% to the stock’s close on Tuesday, a day before Bloomberg News reported that the company was considering options, including a potential sale, after attracting takeover interest.

Read the full article: Vertex Pharmaceuticals to Buy Alpine Immune Sciences for $4.9B //

Source: https://www.reuters.com/markets/deals/vertex-pharmaceuticals-buy-alpine-immune-sciences-49-bln-2024-04-10/

Leave a Comment

Your email address will not be published.

Scroll to Top